T1	Participants 125 176	prevention of mother-to-child transmission of HIV-1
T2	Participants 564 596	pregnant women infected with HIV
T3	Participants 606 662	Pregnant women with WHO stage 1, 2, or 3 HIV-1 infection
T4	Participants 838 866	Women were randomly assigned
